搜尋





搜尋





市場行情
/
股票
/
cstl
/

Castle Biosciences Inc

CSTL

添加自選

28.090USD

+1.300+4.85%

收盤 07-31 16:00（美東）報價延遲15分鐘

856.98M總市值

虧損本益比TTM

Castle Biosciences Inc

28.090

+1.300+4.85%

概覽

財務

分析

公司

財務摘要利潤表資產負債表現金流量表

CSTL 利潤表

您可以在這裡找到Castle Biosciences Inc的年度或季度收入報告，以深入了解Castle Biosciences Inc的營運、管理效率和表現。

單季報

單季報+年報

單季報

年報

YOY

隱藏空白列

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

FY2018Q4

FY2018Q3

FY2018Q2

FY2018Q1

營業總收入

20.14%103.55M

-4.90%83.68M

0.81%87.01M

-3.19%83.04M

-0.94%86.19M

20.57%87.99M

30.54%86.31M

39.50%85.78M

73.53%87.00M

73.59%72.97M

72.47%66.12M

66.15%61.49M

43.92%50.14M

56.55%42.04M

53.11%38.34M

57.66%37.01M

53.08%34.84M

17.70%26.85M

44.74%25.04M

54.27%23.48M

78.99%22.76M

30.97%22.81M

-1.90%17.30M

2.99%15.22M

18.40%12.71M

99.82%17.42M

54.20%17.63M

298.06%14.77M

169.86%10.74M

138.26%8.72M

--11.44M

--3.71M

--3.98M

--3.66M

營業收入

20.14%103.55M

-4.90%83.68M

0.81%87.01M

-3.19%83.04M

-0.94%86.19M

20.57%87.99M

30.54%86.31M

39.50%85.78M

73.53%87.00M

73.59%72.97M

72.47%66.12M

66.15%61.49M

43.92%50.14M

56.55%42.04M

53.11%38.34M

57.66%37.01M

53.08%34.84M

17.70%26.85M

44.74%25.04M

54.27%23.48M

78.99%22.76M

30.97%22.81M

-1.90%17.30M

2.99%15.22M

18.40%12.71M

99.82%17.42M

54.20%17.63M

298.06%14.77M

169.86%10.74M

138.26%8.72M

--11.44M

--3.71M

--3.98M

--3.66M

主營業務成本

32.49%25.95M

-49.09%22.76M

0.33%20.59M

17.33%20.98M

16.83%19.59M

176.98%44.71M

39.67%20.52M

31.57%17.88M

26.00%16.77M

30.13%16.14M

25.22%14.69M

21.73%13.59M

36.01%13.31M

63.38%12.40M

109.37%11.73M

114.96%11.16M

147.48%9.78M

150.73%7.59M

109.69%5.61M

109.86%5.19M

84.20%3.95M

26.64%3.03M

32.95%2.67M

44.85%2.48M

7.69%2.15M

49.63%2.39M

47.16%2.01M

26.50%1.71M

50.19%1.99M

27.53%1.60M

--1.37M

--1.35M

--1.33M

--1.25M

營業費用

17.89%106.62M

-11.93%102.09M

10.43%90.84M

11.33%89.85M

10.30%90.44M

47.77%115.92M

14.60%82.26M

13.45%80.70M

15.00%81.99M

6.64%78.44M

16.77%71.78M

21.18%71.13M

20.42%71.30M

50.72%73.56M

52.87%61.47M

66.34%58.70M

87.55%59.21M

80.12%48.81M

97.78%40.21M

84.59%35.29M

136.29%31.57M

65.41%27.10M

35.34%20.33M

84.79%19.12M

31.87%13.36M

81.25%16.38M

125.26%15.02M

57.62%10.35M

52.44%10.13M

34.03%9.04M

--6.67M

--6.56M

--6.65M

--6.74M

研發費用

14.58%14.54M

14.45%14.30M

15.09%13.44M

5.20%12.87M

-9.67%12.69M

-8.97%12.49M

-9.55%11.68M

-4.71%12.23M

6.25%14.05M

-4.11%13.72M

14.99%12.91M

18.64%12.84M

11.64%13.22M

34.14%14.31M

19.79%11.23M

45.59%10.82M

76.04%11.85M

81.97%10.67M

105.39%9.37M

143.70%7.43M

149.13%6.73M

101.44%5.86M

44.52%4.56M

101.58%3.05M

105.33%2.70M

109.09%2.91M

177.46%3.16M

16.98%1.51M

13.56%1.32M

10.35%1.39M

--1.14M

--1.29M

--1.16M

--1.26M

折舊攤銷及損耗

----

-86.80%3.93M

-34.52%3.78M

7.77%3.82M

1.97%3.41M

791.14%29.76M

78.91%5.77M

11.56%3.54M

10.13%3.35M

15.49%3.34M

13.44%3.22M

8.59%3.17M

15.68%3.04M

34.45%2.89M

95.86%2.84M

168.41%2.92M

314.51%2.63M

823.18%2.15M

806.88%1.45M

815.13%1.09M

521.57%634.00K

156.04%233.00K

60.50%160.00K

30.73%119.00K

16.53%102.00K

13.86%91.00K

12.89%99.69K

9.28%91.03K

8.85%87.53K

0.21%79.92K

--88.30K

--83.30K

--80.42K

--79.75K

其他營業費用

----

100.00%0.00

-100.00%0.00

100.00%0.00

----

---1.88M

--1.88M

---1.88M

----

營業利潤

27.78%-3.07M

34.09%-18.41M

-194.49%-3.83M

-233.96%-6.80M

-184.82%-4.25M

-410.47%-27.93M

171.58%4.05M

152.69%5.08M

123.69%5.01M

82.64%-5.47M

75.54%-5.66M

55.55%-9.64M

13.18%-21.16M

-43.58%-31.52M

-52.48%-23.13M

-83.57%-21.69M

-176.61%-24.37M

-412.46%-21.95M

-400.36%-15.17M

-202.85%-11.81M

-1265.89%-8.81M

-513.51%-4.28M

-216.05%-3.03M

-188.07%-3.90M

-206.15%-645.00K

422.30%1.04M

-45.20%2.61M

255.32%4.43M

122.79%607.62K

89.58%-321.44K

--4.77M

---2.85M

---2.67M

---3.08M

淨非營業利息收入（費用）

利息收入

-19.97%2.36M

-17.88%2.54M

-14.12%2.90M

-16.77%2.83M

-6.36%2.94M

3.44%3.10M

8.11%3.37M

22.93%3.40M

31.05%3.14M

28.25%3.00M

37.10%3.12M

114.15%2.77M

548.38%2.40M

7686.67%2.34M

13282.35%2.27M

5521.74%1.29M

1441.67%370.00K

650.00%30.00K

-10.53%17.00K

27.78%23.00K

-36.84%24.00K

-98.66%4.00K

-93.23%19.00K

246.82%18.00K

587.29%38.00K

1333.45%298.00K

10585.41%280.49K

-60.88%5.19K

146.83%5.53K

286.20%20.79K

--2.63K

--13.27K

--2.24K

--5.38K

利息費用

819.05%193.00K

688.24%134.00K

-73.91%24.00K

-88.06%24.00K

-92.22%21.00K

21.43%17.00K

4500.00%92.00K

9950.00%201.00K

8900.00%270.00K

250.00%14.00K

-50.00%2.00K

-66.67%2.00K

-25.00%3.00K

33.33%4.00K

300.00%4.00K

--6.00K

--4.00K

--3.00K

-99.75%1.00K

-100.00%0.00

-48.43%395.00K

-35.12%706.00K

-54.57%769.00K

-25.42%764.00K

17.83%765.89K

91.31%1.09M

222.49%1.69M

93.20%1.02M

--650.00K

--568.77K

--524.84K

--530.23K

特殊收入（費用）

-153.16%-630.00K

241.89%2.02M

-434.23%-1.85M

--3.56M

--1.19M

---1.43M

--555.00K

----

-100.00%0.00

100.00%0.00

--300.00K

--151.00K

--20.40M

---2.56M

100.00%0.00

----

-324029.93%-1.40M

-100.00%0.00

----

---431.00

--5.21M

----

--0.00

----

其他非經營性收入（費用）

---153.00K

---439.00K

--96.00K

--48.00K

----

100.00%0.00

100.00%-8.00

-6233.34%-2.71M

-657.16%-189.65K

-59.09%-32.93K

---242.96K

---42.80K

--34.04K

---20.70K

稅前利潤

----

45.14%-14.41M

-134.42%-2.71M

-104.66%-386.00K

-101.81%-143.00K

-955.48%-26.27M

410.31%7.88M

220.50%8.28M

142.03%7.89M

91.47%-2.49M

87.64%-2.54M

66.06%-6.87M

-420.42%-18.76M

-19.20%-29.19M

-35.67%-20.56M

-71.73%-20.25M

58.97%-3.60M

-472.17%-24.49M

-215.40%-15.15M

-156.94%-11.79M

-538.52%-8.79M

-850.88%-4.28M

-325.93%-4.80M

-178.45%-4.59M

-8.43%-1.38M

141.97%570.00K

-45.14%2.13M

269.54%5.85M

59.78%-1.27M

62.59%-1.36M

--3.88M

---3.45M

---3.15M

---3.63M

所得稅

107.93%370.00K

125.77%109.00K

77.60%-382.00K

-98.09%115.00K

-351.26%-4.67M

-1040.00%-423.00K

-4471.79%-1.71M

18690.63%6.01M

-6562.50%-1.03M

221.43%45.00K

-31.58%39.00K

--32.00K

100.82%16.00K

-89.55%14.00K

100.65%57.00K

--0.00

-39240.00%-1.96M

--134.00K

-10486.90%-8.72M

--0.00

--5.00K

--0.00

16.67%84.00K

--0.00

736.63%72.00K

--0.00

--8.61K

--0.00

除稅後利潤

----

43.82%-14.52M

-124.32%-2.33M

-122.08%-501.00K

-49.29%4.52M

-920.05%-25.85M

471.71%9.59M

132.86%2.27M

147.50%8.92M

91.32%-2.53M

87.49%-2.58M

65.90%-6.91M

-1039.38%-18.78M

-18.60%-29.20M

-220.65%-20.62M

-71.73%-20.25M

81.25%-1.65M

-475.30%-24.62M

-31.52%-6.43M

-156.94%-11.79M

-538.88%-8.79M

-850.88%-4.28M

-337.93%-4.89M

-178.45%-4.59M

-8.43%-1.38M

141.97%570.00K

-46.88%2.05M

269.54%5.85M

59.78%-1.27M

62.59%-1.36M

--3.87M

---3.45M

---3.15M

---3.63M

持續經營利潤

-137.36%-1.69M

43.82%-14.52M

-124.32%-2.33M

-122.08%-501.00K

-49.29%4.52M

-920.05%-25.85M

471.71%9.59M

132.86%2.27M

147.50%8.92M

91.32%-2.53M

87.49%-2.58M

65.90%-6.91M

-1039.38%-18.78M

-18.60%-29.20M

-220.65%-20.62M

-71.73%-20.25M

81.25%-1.65M

-475.30%-24.62M

-31.52%-6.43M

-156.94%-11.79M

-538.88%-8.79M

-850.88%-4.28M

-337.93%-4.89M

-178.45%-4.59M

-8.43%-1.38M

141.97%570.00K

-46.88%2.05M

269.54%5.85M

59.78%-1.27M

62.59%-1.36M

--3.87M

---3.45M

---3.15M

---3.63M

反常淨利潤

----

--0.00

----

歸属于母公司的淨利潤

-137.36%-1.69M

43.82%-14.52M

-124.32%-2.33M

-122.08%-501.00K

-49.29%4.52M

-920.05%-25.85M

471.71%9.59M

132.86%2.27M

147.50%8.92M

91.32%-2.53M

87.49%-2.58M

65.90%-6.91M

-1039.38%-18.78M

-18.60%-29.20M

-220.65%-20.62M

-71.73%-20.25M

81.25%-1.65M

-475.30%-24.62M

-31.52%-6.43M

-156.94%-11.79M

-538.88%-8.79M

-850.88%-4.28M

-337.88%-4.89M

-182.79%-4.59M

39.24%-1.38M

124.33%570.00K

-28.19%2.06M

224.39%5.54M

44.49%-2.26M

47.82%-2.34M

--2.86M

---4.46M

---4.08M

---4.49M

優先股派息

----

--0.00

-100.00%0.00

----

-69.54%306.47K

7.66%995.67K

14.66%984.37K

--1.01M

--924.80K

--858.55K

歸屬普通股東的淨利潤

-137.36%-1.69M

43.82%-14.52M

-124.32%-2.33M

-122.08%-501.00K

-49.29%4.52M

-920.05%-25.85M

471.71%9.59M

132.86%2.27M

147.50%8.92M

91.32%-2.53M

87.49%-2.58M

65.90%-6.91M

-1039.38%-18.78M

-18.60%-29.20M

-220.65%-20.62M

-71.73%-20.25M

81.25%-1.65M

-475.30%-24.62M

-31.52%-6.43M

-156.94%-11.79M

-538.88%-8.79M

-850.88%-4.28M

-337.88%-4.89M

-182.79%-4.59M

39.24%-1.38M

124.33%570.00K

-28.19%2.06M

224.39%5.54M

44.49%-2.26M

47.82%-2.34M

--2.86M

---4.46M

---4.08M

---4.49M

基本每股收益

-135.54%-0.06

46.22%-0.49

-123.31%-0.08

-121.14%-0.02

-51.52%0.16

-879.92%-0.90

457.24%0.34

131.67%0.08

145.94%0.32

91.60%-0.09

87.78%-0.10

66.56%-0.26

-1010.85%-0.70

-13.33%-1.10

-207.66%-0.78

-65.02%-0.77

81.95%-0.06

-463.73%-0.97

-8.23%-0.25

-102.57%-0.47

-346.72%-0.35

-623.62%-0.17

-297.43%-0.23

-170.91%-0.23

44.42%-0.08

122.48%0.03

-33.39%0.12

216.92%0.32

44.49%-0.14

47.82%-0.15

--0.18

---0.28

---0.25

---0.28

稀釋每股收益

-136.31%-0.06

46.22%-0.49

-125.28%-0.08

-122.33%-0.02

-50.68%0.15

-879.92%-0.90

429.38%0.31

129.99%0.08

144.19%0.31

91.60%-0.09

87.78%-0.10

66.56%-0.26

-1010.85%-0.70

-13.33%-1.10

-207.66%-0.78

-65.02%-0.77

81.95%-0.06

-463.73%-0.97

-8.23%-0.25

-102.57%-0.47

-346.72%-0.35

-664.57%-0.17

-297.43%-0.23

-170.91%-0.23

44.42%-0.08

120.85%0.03

-33.39%0.12

216.92%0.32

44.49%-0.14

47.82%-0.15

--0.18

---0.28

---0.25

---0.28

每股派息

----

--0.00

貨幣單位

--USD

審計意見

----

常見問題

如何在 TradingKey 上查看 Castle Biosciences Inc 的利潤表？



先看總營收，再依序查看營業成本、毛利、營業費用、營業利益、稅前淨利、淨利和每股盈餘（EPS）。營收反映公司的業務規模，而各項獲利和利潤率則體現公司能否有效地將營收轉化為獲利。

季度利潤表和年度利潤表有什麼區別？



季度利潤表反映公司在一個為期三個月的財務季度內的經營表現，年度損益表則彙總整個財年的業績。季度數據適合用於觀察近期發展勢頭和季節性變化，年度數據則更適合評估長期成長、獲利能力和業務週期。

利潤表頁面中的同比是什麼意思？



同比（即年增率，YoY）是指將某項財務指標與上年同期進行比較，例如將本季度營收與去年同一季度的營收進行對比。與去年同期比較的數據有助於投資者觀察成長趨勢，同時減少正常季節性變化對分析的影響。

分析 CSTL 股票時，哪些利潤表指標最重要？



重要的指標包括營收成長、毛利、毛利率、營業利益、營業利益率、淨利、每股盈餘、研發費用、銷售及管理費用以及所得稅費用。投資者通常會綜合分析這些指標，以判斷公司是否正在成長、有效控制成本並提升獲利能力。

Castle Biosciences Inc 財年末的營收是多少？



Castle Biosciences Inc 2025 財年營收為 344.23M，高於上一財年的 332.07M。

Castle Biosciences Inc 最近一個季度的營收是多少？



Castle Biosciences Inc 最近一個季度的營收為 103.55M，同比增長 20.14%。

Castle Biosciences Inc 全年的淨利潤是多少？



Castle Biosciences Inc 2025 財年淨利潤為 -24.16M。

Castle Biosciences Inc 上一季度的淨利潤是多少？



Castle Biosciences Inc 最近一個季度的淨利潤為 -1.69M。

Castle Biosciences Inc 年度營業利潤是多少？



Castle Biosciences Inc 2025 財年的營業利潤為 -42.81M。

每股收益與利潤表有什麼關係？



每股收益（EPS）通常以淨利潤除以流通在外的股份數量計算，用於衡量公司平均每股創造的利潤。分析 EPS 時，還應結合股本變化、利潤率、現金流和估值指標進行綜合判斷。